From: Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
Hemodialysis, n = 12,159 | Peritoneal dialysis, n = 913 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHF | CVD | Diabetes | CHF | CVD | Diabetes | |||||||||
Medication | All | Yes | No | Yes | No | Yes | No | All | Yes | No | Yes | No | Yes | No |
None | 12 | 10 | 13 | 11 | 13 | 10 | 15 | 10 | 7 | 10 | 7 | 11 | 5 | 14 |
Beta-blocker | ||||||||||||||
Any | 59 | 65 | 55 | 64 | 53 | 62 | 54 | 55 | 69 | 51 | 67 | 48 | 61 | 48 |
Alpha-beta | 19 | 26 | 13 | 22 | 15 | 20 | 16 | 13 | 25 | 10 | 17 | 11 | 16 | 10 |
Beta not alpha | 41 | 39 | 42 | 43 | 38 | 42 | 38 | 42 | 44 | 41 | 51 | 37 | 45 | 38 |
RAS * | ||||||||||||||
Any | 45 | 45 | 45 | 44 | 46 | 49 | 39 | 52 | 54 | 51 | 55 | 50 | 57 | 46 |
ACEI | 32 | 32 | 31 | 31 | 32 | 34 | 27 | 33 | 36 | 32 | 34 | 32 | 35 | 30 |
ARB | 17 | 16 | 17 | 16 | 18 | 19 | 14 | 23 | 22 | 23 | 25 | 22 | 26 | 19 |
CCB | ||||||||||||||
Any | 49 | 44 | 52 | 45 | 52 | 49 | 47 | 50 | 43 | 51 | 48 | 51 | 54 | 44 |
DHP | 40 | 36 | 43 | 37 | 43 | 41 | 39 | 40 | 35 | 41 | 38 | 41 | 42 | 37 |
Non-DHP | 9 | 8 | 9 | 8 | 9 | 9 | 8 | 10 | 8 | 10 | 10 | 10 | 13 | 7 |
Diuretic † | ||||||||||||||
Any | 28 | 31 | 24 | 28 | 26 | 31 | 21 | 41 | 55 | 37 | 52 | 35 | 50 | 32 |
Loop | 26 | 30 | 22 | 26 | 24 | 29 | 19 | 38 | 53 | 34 | 50 | 33 | 47 | 29 |
Thiazide | 5 | 5 | 4 | 4 | 5 | 5 | 3 | 9 | 13 | 8 | 13 | 6 | 12 | 5 |
Alpha blocker | 7 | 6 | 7 | 7 | 6 | 7 | 7 | 10 | 8 | 10 | 12 | 9 | 11 | 7 |
Central alpha 2 agonist | 19 | 18 | 20 | 17 | 21 | 20 | 18 | 15 | 14 | 16 | 14 | 16 | 16 | 14 |
Hydralazine | 8 | 11 | 6 | 9 | 7 | 9 | 7 | 4 | 9 | 3 | 5 | 4 | 6 | 3 |
Minoxidil | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 2 | 2 | 3 | 1 | 3 | 2 | 2 |